Previous 10 | Next 10 |
2U (NASDAQ: TWOU ) -41% on Q2 earnings . More news on: 2U, Inc., Sigma Labs, Inc., T2 Biosystems, Inc., Stocks on the move, Read more ...
Nano cap T2 Biosystems (NASDAQ: TTOO ) slumps 35% premarket on modest volume on the heels of its Q2 report released after the close yesterday. More news on: T2 Biosystems, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
T2 Biosystems, Inc. (TTOO) Q2 2019 Earnings Conference Call July 30, 2019 4:30 PM ET Company Participants Matt Clawson - Investor Relations John McDonough - President & Chief Executive Officer John Sprague - Chief Financial Officer Tom Lowery - Chief Scientific Officer Sa...
T2 Biosystems, Inc. (NASDAQ: TTOO ): Q2 GAAP EPS of -$0.35 misses by $0.02 . More news on: T2 Biosystems, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Announces Two Financing Agreements to Potentially Provide up to $60 Million of Additional Capital; Reducing Cash Burn by 30% by Q4 2019 Achieved $1.8 Million in Total Revenue and Secured 12 New T2Dx® Instrument Contracts Updates 2019 Financial Guidance Announced Managemen...
LEXINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (the “Company”) (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John Sprague, Chief F...
T2 Biosystems, Inc. (NASDAQ: TTOO ) is scheduled to announce Q2 earnings results on Tuesday, July 30th, after market close. The consensus EPS Estimate is -$0.33 (-3.1% Y/Y) and the consensus Revenue Estimate is $1.95M (-50.4% Y/Y). Over the last 1 year, ttoo has beaten EPS estimates ...
LEXINGTON, Mass., July 26, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it entered into exclusive distribution agreements with five new distribution...
LEXINGTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2019 second quarter financial and oper...
Before I get into the main theme of the article, I want to make a market-cap comparison of T2 Biosystems ( TTOO ) and Accelerate Diagnostics ( AXDX ). Reason being, to investigate if TTOO is undervalued in comparison to AXDX or not. AXDX is a Vitro diagnostics company that offers a diag...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the first quarter 2024 and business updates after mar...
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financia...
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion ...